Essex Financial Services, Inc.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1315785 ESSEX, CT

Position in NBIX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$235,787

-$6,351 QoQ

Shares Held

1,399

-23.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#575

of 768 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Essex Financial Services, Inc. holds $1,417,935 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (16.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	16,075	$544,621
2	VTRS	Viatris Inc	26,362	$418,628
3	NBIX	Neurocrine Biosciences Inc This page	1,399	$235,787
4	UTHR	UNITED THERAPEUTICS Corp	404	$218,899

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$235,787	1,399	-23.9%	Shares	Sole	2026-08-10
2026-03-31	$242,138	1,838	+19.7%	Shares	Sole	2026-04-24
2025-12-31	$217,850	1,536	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.